Search results
Results from the Go Local Guru Content Network
The Dana–Farber/Harvard Cancer Center is the largest National Cancer Institute (NCI) designated Comprehensive Cancer Center in the nation. Founded in 1997, DF/HCC is an inter-institutional research enterprise that unites all of the cancer research efforts of the Harvard affiliated community. The primary goal of the Cancer Center is to ...
Dana–Farber Cancer Institute. Sidney Farber (September 30, 1903 – March 30, 1973) was an American pediatric pathologist. He is regarded as the father of modern chemotherapy for his work using folic acid antagonists to combat leukemia, which led to the development of other chemotherapeutic agents against other malignancies.
The informational picket will be Friday from 4 to 5:30 p.m. Nurses who care for oncology patients at the facility voted to join the Massachusetts Nurses Association in July 2022. Nurses say they ...
The Dana-Farber Cancer Institute reinstated the mask mandate this week along with requiring that anyone experiencing any type of cold, flu or COVID-19 symptoms contact their doctor's office before ...
To contribute to the Dana-Farber Marathon Challenge, go online to www.RunDFMC.org or contact the Dana-Farber Marathon Challenge office at (617) 632-1970 or dfmc@dfci.harvard.edu. Follow DFMC on ...
Cancer immunotherapy. Institutions. Harvard Medical School. Dana–Farber Cancer Institute. Laurie Hollis Glimcher (born 1951) is an American physician-scientist who was appointed president and CEO of Dana–Farber Cancer Institute in October 2016. [1] She was elected a Member of the American Philosophical Society in 2019.
Nurses represented by the union are "prepared to strike for 24 hours – and picket in front of DFCI – MV during regular clinic hours – after repeatedly trying to get Dana-Farber executives to ...
Catherine J. Wu. Catherine J. Wu is an American physician-scientist who studies oncology. She is a Professor of Medicine and Chief of Division of Stem Cell Transplantation and Cellular Therapies at the Dana–Farber Cancer Institute. Her research focuses on longitudinal studies of patients with chronic lymphocytic leukemia (CLL).
“It is outrageous that Dana-Farber executives would rather spend untold money on travelers and lock us out rather than simply meet the needs of nurses and support the cancer care we provide in ...
Proceeds from the event will benefit adult and pediatric patient care and cancer research at Dana-Farber. In 2017, the Dana-Farber team celebrates its 15th year of participation in the race’s ...